INS and Insulin resistance: In our results, the increase of insulin AUC, triglycerides and VLDL for the baseline–end intragroup analysis for placebo group patients are expected changes since insulin resistance is directly associated to insulin secretion as well as to triglycerides and VLDL concentrations [1,3,31,41].